Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1991
10/10/1991DE4011375A1 New anticoagulant hirudin-polyvinyl lactam conjugates - for treating e.g. myocardial infarction, peripheral arterial occlusion disorders, deep venous thrombosis and pulmonary embolism
10/10/1991DE4011207A1 Humane splenopentinderivate und verfahren zu deren herstellung Human splenopentinderivate and processes for their preparation
10/10/1991CA2080371A1 T-cell suppressor protein
10/09/1991EP0450936A1 Monoclonal antibody to avermectins
10/09/1991EP0450800A1 Utilization and delivery of enzymes
10/09/1991EP0450598A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor
10/09/1991EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections
10/09/1991EP0450480A2 Somatostatin Analogues
10/09/1991EP0450479A1 Bispecific monoclonal anti-bodies, their production and use
10/09/1991EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma
10/09/1991EP0450461A2 LHRH Analogs
10/09/1991EP0450412A1 Heat-treated IgM antibody preparations
10/09/1991EP0450386A2 Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins
10/09/1991EP0450352A1 Liposome formulations of immunomodulating drugs for the topical and aerosol administrations
10/09/1991EP0450240A1 Anti-aids preparation
10/09/1991EP0450100A1 Physiologically active peptide
10/09/1991EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor
10/09/1991EP0449973A1 Polypeptide-polymer conjugates active in wound healing.
10/09/1991EP0449972A1 Triple stranded nucleic acid and methods of use
10/09/1991EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase
10/09/1991EP0449956A1 Novel lymphokine/cytokine genes
10/09/1991EP0449949A1 Use of interleukin-4 for lowering blood-cholesterol levels
10/09/1991EP0449948A1 Grafting genetically modified cells to treat diseases of the central nervous system
10/09/1991EP0449943A1 Transdermal and intranasal administration of renin inhibitory peptides
10/09/1991EP0449915A1 New tnf peptides
10/09/1991EP0449884A1 Derivatives of tetrapeptides as cck agonists
10/09/1991EP0449879A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents
10/09/1991EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom
10/09/1991EP0449828A1 HUMAN Fc$g(g) RECEPTOR III
10/09/1991EP0231236B1 Purification of hemoglobin and modified hemoglobin by affinity chromatography
10/09/1991CN1055116A Method for producting pharmaceutical composition containing il-4 as active ingredient
10/08/1991WO1991015220A1 Products containing a lithium salt and a tumour necrosis factor
10/08/1991US5055591 Process for the preparation of octahydropenta(b)pyrrole carboxylates
10/08/1991US5055554 Renal growth promoter and process for the production of the same
10/08/1991US5055553 Low molecular weight pulmonary surfactant proteins
10/08/1991US5055483 Hypotensive agents, cognition activators, learning enrichment
10/08/1991US5055464 Cognition activators, diuretics, antiulcer agents
10/08/1991US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material
10/08/1991US5055451 Prevent tissue damage
10/08/1991US5055450 Di-, tri- and tetrapeptides as inhibitors of human leukocyte elastase
10/08/1991US5055449 With peptide to reduce neuropathic side effects
10/08/1991US5055448 Diuretics
10/08/1991US5055447 Administering transforming growth factor beta
10/08/1991US5055446 Less than ten percent of calories from protein, remainder is from lipids and carbohydrates
10/08/1991US5055400 Cloning and expression of leukotoxin gene of pasteurella in suitable host microorganism
10/08/1991US5055391 Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2)
10/08/1991US5055302 Nearsightedness
10/08/1991US5055295 Synergistic
10/08/1991US5055291 Compositions for preventing secondary cataracts
10/08/1991US5055289 Dual specificity against therapeutically active agent and against a disease related antigen
10/08/1991US5055287 For oral cavitiy; containing peroxidase, peroxide and iodide salt with decolorizer such as malonic acid, sorbic acid
10/08/1991CA2065012A1 Products containing a lithium salt and a tumor necrosis fac tor
10/08/1991CA1290267C Human anti-inflammatory phospholipase inhibitor protein
10/08/1991CA1290249C COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
10/08/1991CA1290248C Treatment of infections with lymphokines
10/08/1991CA1290245C Methods for diagnosis and therapy of multiple sclerosis
10/07/1991WO1991015516A2 Hepatitis c virus epitopes
10/07/1991WO1991015515A1 Method and composition for treating thrombosis
10/07/1991WO1991015230A1 Ligand for the neu gene product
10/07/1991CA2079606A1 Method and composition for treating thrombosis
10/07/1991CA2039985A1 Method of curing and preventing obesity by o-amylase inhibitor
10/07/1991CA2039908A1 Lhrh analogues
10/07/1991CA2039880A1 Somatostatin analogues
10/07/1991CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
10/06/1991CA2039628A1 Platelet-aggregation inhibitors
10/06/1991CA2039541A1 Monoclonal antibodies to avermectins
10/05/1991WO1991015575A1 Hepatitis c virus protease
10/05/1991WO1991015229A1 Modified heparin binding growth factors
10/05/1991WO1991015222A2 Method of predisposing mammals to accelerated tissue repair
10/05/1991CA2079604A1 Modified heparin binding growth factors
10/05/1991CA2078547A1 Method of predisposing mammals to accelerated tissue repair
10/05/1991CA2013900A1 Anti-aids preparation
10/04/1991WO1991015512A2 Hiv envelope polypeptides
10/04/1991WO1991015510A1 Epithelins: novel cysteine - rich growth modulating proteins
10/04/1991WO1991015239A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria
10/04/1991CA2079804A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria
10/04/1991CA2079218A1 Epithelins: novel cysteine-rich growth modulating proteins
10/04/1991CA2078545A1 Hiv envelope polypeptides
10/04/1991CA2039542A1 Inhibitors of the advanced glycosylation of proteins and methods of use therefor
10/04/1991CA2022523A1 Chemically modified cd4 peptide fragments having anti-retroviral properties
10/03/1991WO1991015593A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
10/03/1991WO1991014790A1 Inhibitors of transcription activation activity of papillomaviruses
10/03/1991WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus
10/03/1991WO1991014777A1 Isoform of platelet-derived growth factor a chain
10/03/1991WO1991014775A1 Gp75 as a tumor vaccine for melanoma
10/03/1991WO1991014772A1 Production of enzymes in seeds and their use
10/03/1991WO1991014767A1 Method for enhanced growth and proliferation of mast cells
10/03/1991WO1991014704A2 Treatment of polycystic ovarian disease
10/03/1991WO1991014702A1 Anti-tumour peptides
10/03/1991WO1991014701A1 Improved major histocompatibility complex (mhc) molecules
10/03/1991WO1991014698A1 Marine tyrosinase gene
10/03/1991WO1991014695A1 Insect retinoid receptor compositions and methods
10/03/1991WO1991014454A1 Pharmaceutical formulations
10/03/1991WO1991014451A1 Bcrf1 antagonists for treating epstein-barr virus infections
10/03/1991WO1991014450A1 Use of il-4 to enhance immune response to infectious antigenic challenges
10/03/1991WO1991014449A1 Induction of protection against viral infection
10/03/1991WO1991014448A1 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
10/03/1991WO1991014446A1 Crf analogs
10/03/1991WO1991014444A1 Treatment of cachexia with interleukin 2
10/03/1991WO1991014443A1 A method for regulating neuron development and maintenance